Quazodine

This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G66N97788I, chemically known as 6,7-dimethoxy-4-ethylquinazoline but generally known as quazodine, which bears US NIH Compound Identifier 19918. European Medicines Agency schedules Quazodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10190MIG. The term QUAZODINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). QUAZODINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quazodine under HS 29335995 and SITC 51576. As of Q4 2014, QUAZODINE remains the US FDA Preferred Term for this commodity. Quazodine bears US NLM identifiers UMLS ID C0072830 and NCI Concept Code C80615. SMILES: CCC1=NC=NC2=CC(=C(C=C21)OC)OC.